Medicare Part B Drug Payments: Impact of Price Substitutions Based on 2023 Average Sales Prices
(Source – oig.hhs.gov) Medicare Part B annually spends billions of dollars to cover a limited number of outpatient prescription drugs.
Read More(Source – oig.hhs.gov) Medicare Part B annually spends billions of dollars to cover a limited number of outpatient prescription drugs.
Read More(Source – The Kaiser Family Foundation published August 4, 2025) On July 4, President Trump signed the budget reconciliation bill,
Read More(By: Alexandra Murphy for Becker’s Hospital Review) Here are seven new drugs and discontinuations, according to drug supply databases from
Read More(By: Alexandra Murphy for Becker’s Hospital Review) Pharmaceutical prices are expected to rise by 3.35% in 2026, according to Vizient’s latest
Read More(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul
Read MoreThe Centers for Medicare & Medicaid Services (CMS) has released preliminary technical Medicare Part D bid information for the 2026
Read More(By Nancy Ochieng, Meredith Freed, Jeannie Fuglesten Biniek, Anthony Damico, and Tricia Neuman for The Kaiser Family Foundation Published: Jul
Read More(By: Alexandra Murphy for Becker’s Hospital Review) As federal scrutiny and legislative proposals continue around the 340B drug pricing program,
Read More(By Juliette Cubanski and Tricia Neuman for KFF Health News Published: Jul 16, 2025) Ahead of Medicare’s annual mid-year announcement
Read More(By Juliette Cubanski and Anthony Damico for The Kaiser Family Foundation Published: Jul 16, 2025) The Medicare Part D program
Read More